Adma Biologics Inc’s recently made public that its President and CEO Grossman Adam S unloaded Company’s shares for reported $0.39 million on Jul 15 ’25. In the deal valued at $18.66 per share,21,000 shares were sold. As a result of this transaction, Grossman Adam S now holds 2,037,850 shares worth roughly $40.57 million.
Then, Grossman Adam S bought 63,000 shares, generating $1,176,840 in total proceeds.
Before that, Grossman Adam S sold 21,000 shares. Adma Biologics Inc shares valued at $437,010 were divested by the President and CEO at a price of $20.81 per share. As a result of the transaction, Grossman Adam S now holds 2,043,850 shares, worth roughly $40.69 million.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Monday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 3.00% to $19.91. Over the last five days, the stock has gained 10.61%. Adma Biologics Inc shares have risen nearly 62.13% since the year began. Nevertheless, the stocks have risen 16.09% over the past one year.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2025-07-15, growing by 0.66 million shares to a total of 14.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 13.81 million shares. There was a rise of 4.59%, which implies that there is a positive sentiment for the stock.
